RxNorm Semantic Concepts Index - 382
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "382".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 3820 | Emetine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3820 | Emetine | Designated preferred name (PT) | NO | |
| RxCUI: 3820 | Emetine | Full form of descriptor (FN) | NO | |
| RxCUI: 3820 | Emetine | Designated preferred name (PT) | NO | |
| RxCUI: 3820 | Emetine | Full form of descriptor (FN) | NO | |
| RxCUI: 38201 | Thymidylate 5'-nucleotidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38201 | Thymidylate 5'-nucleotidase | Designated preferred name (PT) | NO | |
| RxCUI: 38201 | Thymidylate 5'-nucleotidase | Full form of descriptor (FN) | NO | |
| RxCUI: 38209 | Thymine 7-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38209 | Thymine 7-hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 38209 | Thymine 7-hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 38217 | thymomodulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3822 | Emollient product | Designated preferred name (PT) | NO | |
| RxCUI: 3822 | Emollient product | Full form of descriptor (FN) | NO | |
| RxCUI: 3822 | Emollient product | Designated preferred name (PT) | NO | |
| RxCUI: 3822 | Emollient product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3822 | Emollient product | Full form of descriptor (FN) | NO | |
| RxCUI: 38221 | Thymosin alpha 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 38221 | Thymosin alpha 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38221 | Thymosin alpha 1 | Designated preferred name (PT) | NO | |
| RxCUI: 38221 | Thymosin alpha 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 38221 | Thymosin alpha 1 | Designated preferred name (PT) | NO | |
| RxCUI: 38221 | Thymosin alpha 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382271 | Trans fat | Designated preferred name (PT) | NO | |
| RxCUI: 382271 | Trans fat | Full form of descriptor (FN) | NO | |
| RxCUI: 382272 | linoleic acids, conjugated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 382306 | COX-2 inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 382306 | COX-2 inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 382317 | Thiazolidinedione | Full form of descriptor (FN) | NO | |
| RxCUI: 382317 | Thiazolidinedione | Designated preferred name (PT) | NO | |
| RxCUI: 382317 | Thiazolidinedione | Full form of descriptor (FN) | NO | |
| RxCUI: 382317 | Thiazolidinedione | Designated preferred name (PT) | NO | |
| RxCUI: 38233 | thymostimulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38233 | thymostimulin | Designated preferred name (PT) | NO | |
| RxCUI: 38233 | thymostimulin | Full form of descriptor (FN) | NO | |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 38234 | Thymus leukemia (TL) antigen | Designated preferred name (PT) | NO | |
| RxCUI: 382350 | Zymar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 382362 | Carboxypeptidase A2 | Designated preferred name (PT) | NO | |
| RxCUI: 382362 | Carboxypeptidase A2 | Full form of descriptor (FN) | NO | |
| RxCUI: 38238 | 3,5-dinitrotyrosine aminotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38238 | 3,5-dinitrotyrosine aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 38238 | 3,5-dinitrotyrosine aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 38240 | Thyroid microsomal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 38240 | Thyroid microsomal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 38240 | Thyroid microsomal antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38240 | Thyroid microsomal antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38240 | Thyroid microsomal antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38243 | Thyrotropin beta subunit | Designated preferred name (PT) | NO | |
| RxCUI: 38243 | Thyrotropin beta subunit | Full form of descriptor (FN) | NO | |
| RxCUI: 382467 | Reyataz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 38248 | tiadenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38248 | tiadenol | Designated preferred name (PT) | NO | |
| RxCUI: 38248 | tiadenol | Full form of descriptor (FN) | NO | |
| RxCUI: 38249 | tiadilon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38252 | tianeptine | Full form of descriptor (FN) | NO | |
| RxCUI: 38252 | tianeptine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38252 | tianeptine | Designated preferred name (PT) | NO | |
| RxCUI: 38252 | tianeptine | Full form of descriptor (FN) | NO | |
| RxCUI: 38252 | tianeptine | Designated preferred name (PT) | NO | |
| RxCUI: 38253 | tiaprofenic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 38253 | tiaprofenic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 38253 | tiaprofenic acid | Designated preferred name (PT) | NO | |
| RxCUI: 38253 | tiaprofenic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 38253 | tiaprofenic acid | Designated preferred name (PT) | NO | |
| RxCUI: 38260 | tibolone | Full form of descriptor (FN) | NO | |
| RxCUI: 38260 | tibolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38260 | tibolone | Designated preferred name (PT) | NO | |
| RxCUI: 38260 | tibolone | Full form of descriptor (FN) | NO | |
| RxCUI: 38260 | tibolone | Designated preferred name (PT) | NO | |
| RxCUI: 38261 | Ticarbodine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 38264 | Tiemonium iodide | Designated preferred name (PT) | NO | |
| RxCUI: 38264 | Tiemonium iodide | Full form of descriptor (FN) | NO | |
| RxCUI: 38265 | tiemonium methylsulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 38265 | tiemonium methylsulfate | Designated preferred name (PT) | NO | |
| RxCUI: 38265 | tiemonium methylsulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 382677 | butamirate citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 3827 | Enalapril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3827 | Enalapril | Designated preferred name (PT) | YES | |
| RxCUI: 3827 | Enalapril | Full form of descriptor (FN) | YES | |
| RxCUI: 3827 | Enalapril | Designated preferred name (PT) | YES | |
| RxCUI: 3827 | Enalapril | Full form of descriptor (FN) | YES | |
| RxCUI: 38278 | tilmicosin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 38278 | tilmicosin | Designated preferred name (PT) | NO | |
| RxCUI: 38278 | tilmicosin | Full form of descriptor (FN) | NO | |
| RxCUI: 38283 | Timentin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 3829 | Enalaprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3829 | Enalaprilat | Designated preferred name (PT) | YES | |
| RxCUI: 3829 | Enalaprilat | Full form of descriptor (FN) | YES | |
| RxCUI: 3829 | Enalaprilat | Designated preferred name (PT) | YES | |
| RxCUI: 3829 | Enalaprilat | Full form of descriptor (FN) | YES | |
| RxCUI: 38298 | tioconazole | Full form of descriptor (FN) | YES | |
| RxCUI: 38298 | tioconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 38298 | tioconazole | Designated preferred name (PT) | YES | |
| RxCUI: 38298 | tioconazole | Full form of descriptor (FN) | YES | |
| RxCUI: 38298 | tioconazole | Designated preferred name (PT) | YES |